A detailed history of Exodus Point Capital Management, LP transactions in Haemonetics Corp stock. As of the latest transaction made, Exodus Point Capital Management, LP holds 29,276 shares of HAE stock, worth $2.34 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
29,276
Holding current value
$2.34 Million
% of portfolio
0.02%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$81.24 - $97.37 $2.38 Million - $2.85 Million
29,276 New
29,276 $2.42 Million
Q2 2023

Aug 10, 2023

SELL
$80.84 - $89.45 $3.22 Million - $3.56 Million
-39,809 Reduced 79.25%
10,423 $887,000
Q1 2023

May 11, 2023

BUY
$72.75 - $90.6 $897,153 - $1.12 Million
12,332 Added 32.54%
50,232 $4.16 Million
Q4 2022

Feb 13, 2023

BUY
$73.85 - $86.14 $2.8 Million - $3.26 Million
37,900 New
37,900 $2.98 Million
Q1 2022

May 13, 2022

SELL
$43.77 - $63.22 $250,627 - $361,997
-5,726 Closed
0 $0
Q4 2021

Feb 11, 2022

BUY
$49.55 - $74.59 $283,723 - $427,102
5,726 New
5,726 $304,000
Q2 2021

Aug 16, 2021

SELL
$51.81 - $118.56 $311,637 - $713,138
-6,015 Closed
0 $0
Q1 2021

May 17, 2021

SELL
$111.01 - $139.48 $3.6 Million - $4.53 Million
-32,473 Reduced 84.37%
6,015 $668,000
Q4 2020

Feb 16, 2021

SELL
$88.75 - $119.95 $1.26 Million - $1.7 Million
-14,171 Reduced 26.91%
38,488 $4.57 Million
Q3 2020

Nov 16, 2020

BUY
$75.65 - $93.58 $1.08 Million - $1.33 Million
14,258 Added 37.13%
52,659 $4.59 Million
Q2 2020

Aug 14, 2020

BUY
$84.96 - $118.91 $3.26 Million - $4.57 Million
38,401 New
38,401 $3.44 Million
Q1 2020

May 15, 2020

SELL
$74.34 - $121.82 $2.49 Million - $4.07 Million
-33,437 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$114.37 - $129.46 $3.82 Million - $4.33 Million
33,437 New
33,437 $3.84 Million

Others Institutions Holding HAE

About HAEMONETICS CORP


  • Ticker HAE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 51,316,500
  • Market Cap $4.1B
  • Description
  • Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...
More about HAE
Track This Portfolio

Track Exodus Point Capital Management, LP Portfolio

Follow Exodus Point Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Exodus Point Capital Management, LP with notifications on news.